Biopharmaceutical company focused on rare respiratory diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | LMH STRATEGIC SOLUTIONS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | LMH STRATEGIC SOLUTIONS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | LMH STRATEGIC SOLUTIONS |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| LMH STRATEGIC SOLUTIONS | 3 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 3 |
| Medicare/Medicaid | 2 |
| Health Issues | 1 |